Immutep Limited ( IMMP) - Key Metrics
IMMP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $0.07 | -$0.24 | -$0.20 | -$0.20 |
| 2026Q2 | $0.04 | -$0.31 | -$0.19 | -$0.19 |
| 2025Q4 | $0.01 | -$0.27 | -$0.23 | -$0.23 |
| 2025Q2 | $0.02 | -$0.15 | -$0.20 | -$0.20 |
| 2024Q4 | $0.01 | -$0.18 | -$0.14 | -$0.15 |
IMMP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | -0.65 |
| 2026Q2 | 0% | -3.51 |
| 2025Q4 | 0% | -2.32 |
| 2025Q2 | 0% | -5.69 |
| 2024Q4 | 0% | -4.26 |
IMMP
Price: $3.17
52 week price:
Earnings Per Share: -0.39 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Australia
Volume: 112316
Market Capitalization: 32.1 million